Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2003
12/18/2003CA2486270A1 Vegfr modulating agents and methods for liver growth and liver protection
12/18/2003CA2485874A1 T cell receptor cdr3 sequences and methods for detection
12/18/2003CA2485709A1 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor
12/18/2003CA2480619A1 Novel oxidase
12/17/2003EP1371730A2 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
12/17/2003EP1371728A1 Gene encoding adseverin
12/17/2003EP1371664A1 Wti modified peptide
12/17/2003EP1371663A1 Thrombin derivatives and process for producing the same, anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing compositions, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process
12/17/2003EP1371660A1 Vaccine
12/17/2003EP1371377A1 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof
12/17/2003EP1371373A1 Recombination super compound interferon used as hepatitis b surface antigen and e antigen inhibitor
12/17/2003EP1370697A1 Peroxiredoxin drugs for treatment of hiv-1 infection and methods of use thereof
12/17/2003EP1370676A2 Mouse cytokine receptor
12/17/2003EP1370675A1 Novel nucleic acids and polypeptides
12/17/2003EP1370662A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
12/17/2003EP1370661A2 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
12/17/2003EP1370659A2 Proteins, polynucleotides encoding them and methods of using the same
12/17/2003EP1370657A2 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
12/17/2003EP1370655A2 Secreted human proteins
12/17/2003EP1370654A2 Chimpanzee erythropoietin (chepo) immunoadhesins
12/17/2003EP1370649A1 Protein c variants
12/17/2003EP1370587A2 Antiangiogenic peptides derived from endostatin
12/17/2003EP1370586A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370585A2 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
12/17/2003EP1370584A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370583A1 Polypeptides and nucleic acids for bolekine
12/17/2003EP1370582A1 Peptide analogues of myelin basic protein epitopes in the treatment of experimental autoimmune encephalomyelitis (eae) and multiple sclerosis (ms)
12/17/2003EP1370580A2 A new essential downstream component of the wingless signalling pathway
12/17/2003EP1370579A1 Matrix gene expression in chondrogenesis
12/17/2003EP1370576A1 Methods and compositions for modulating tumor suppression
12/17/2003EP1370575A2 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
12/17/2003EP1370573A2 Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals
12/17/2003EP1370572A2 Mitochondrial membrane permeabilization by hiv-1 vpr and methods of screening
12/17/2003EP1370558A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
12/17/2003EP1370352A1 Method for encapsulating fine solid particles in the form of microcapsules
12/17/2003EP1370299A1 Nucleic acid constructs, cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension
12/17/2003EP1370298A1 Elongated and multiple spacers in activatible prodrugs
12/17/2003EP1370297A2 Method and composition
12/17/2003EP1370292A1 Use of cd23 antagonists for the treatment of neoplastic disorders
12/17/2003EP1370290A2 Molecular antigen array
12/17/2003EP1370287A2 Method and composition for modulating bone growth
12/17/2003EP1370286A1 Compositions of multimeric profilin for diagnosis and treatment of allergies
12/17/2003EP1370282A2 Method for treating ischemic events affecting the central nervous system
12/17/2003EP1370281A2 Human growth hormone for treating children with abnormal short stature and kits and methods for diagnosing gs protein dysfunctions
12/17/2003EP1370280A2 Stabilized interleukin 2
12/17/2003EP1370279A2 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
12/17/2003EP1370278A1 Immunomodulatory properties of bip
12/17/2003EP1370277A1 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis
12/17/2003EP1370276A2 Medical uses of intercellular communication facilitating compounds
12/17/2003EP1370275A2 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside
12/17/2003EP1370259A1 Use of melatonin in the manufacture of a medicament for treating attention deficit hyperactive disorder
12/17/2003EP1370248A1 Compositions and methods for preventing platenet aggegation
12/17/2003EP1370246A2 Modulation of release from dry powder formulations
12/17/2003EP1370240A1 Neuroprotectants formulations and methods
12/17/2003EP1370237A2 Presbyopia treatment by lens alteration
12/17/2003EP1370211A2 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
12/17/2003EP1224210B1 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them
12/17/2003EP1196148B1 Process for microencapsulation of water soluble substances
12/17/2003EP1115414B1 Inhibition of erythrocyte sickling by n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester
12/17/2003EP1066043B1 Materials for the treatment of conditions involving mast cells, basophils and eosinophils
12/17/2003EP1032370B1 Porous hydroxyapatite particles as carriers for drug substances
12/17/2003EP1028715B1 Dosage composition for nasal delivery comprising vibrio cholera zonula occludens toxin as absorption enhancer
12/17/2003EP1009420B1 Conjugates useful in the treatment of prostate cancer
12/17/2003EP1007074B1 Hypothalamus-specific polypeptides
12/17/2003EP0984981B1 Anti-inflammatory tyrosine derivatives
12/17/2003EP0954580B1 Human sdf-5 protein and compositions
12/17/2003EP0922101B1 Egf-like factor from chromaffin granules and glia cell-derived neurotrophic factor with survival-promoting activity on daergic neurons
12/17/2003EP0852490B1 Emulsion formulations for the delivery of nucleic acids to cells
12/17/2003EP0839154B1 Biologically active peptides and compositions, their use
12/17/2003EP0690132B1 Anti-hiv monoclonal antibody
12/17/2003EP0672131B1 A novel cell cycle control protein
12/17/2003EP0641218B1 Use of angiotensin antagonist (at1) for reducing post myocardial infarct mobidity and mortality
12/17/2003EP0571387B1 A non-mitogenic competitive hgf antagonist
12/17/2003EP0552142B2 T cell receptor peptides as therapeutics for autoimmune and malignant disease
12/17/2003CN1462309A Codon-optimized papilloma virus sequences
12/17/2003CN1462277A Pharmaceutical composition comprising analgesic peptide
12/17/2003CN1462276A Peptide-based compounds
12/17/2003CN1462192A Blood cell production via activation of hemeglobin scavenger receptor
12/17/2003CN1462191A Treatment of ocute coronary syndrome with GLP-1
12/17/2003CN1462190A The use of copolymer 1 and related peptides and polypeptides and T cell treated therewith for neuroprotective therapy
12/17/2003CN1461752A Humon leukemia related reverse transcrigt virus genome coded protein and polypeptide sequence and its application
12/17/2003CN1461655A Thrombolytics enzyme contg. venin for injection
12/17/2003CN1131433C Process for testing bioactivity of insulinotropic hormone section peptide
12/17/2003CN1131309C IL-6 mutein
12/17/2003CN1131069C Anti-disease silk increasing agent for silk worm
12/17/2003CN1131068C Composite lysostaphin enzyme spray for oral cavity and its preparing process
12/17/2003CN1131030C Sleep regulating composition prepared with melatonin and diazepam
12/16/2003US6664385 Kidney injury-related molecules
12/16/2003US6664383 Polypeptides, cDNA encoding the same and utilization thereof
12/16/2003US6664378 Use of kits containing an antibody binding a specific urogenital carcinoma tumor liberated protein (TLP) epitope for identifying TLP and for diagnosing urogenital carcinoma.
12/16/2003US6664377 Use of polypeptides comprising a portion of a prostate tumor protein and to polynucleotide molecules encoding such poly-peptides and kits containing vaccines and pharmaceutical compositions for treatment of prostate cancer
12/16/2003US6664374 Polypeptides comprising IL-6 ligand-binding receptor domains
12/16/2003US6664373 TWIK-5 potassium channel polypeptides and uses therefor
12/16/2003US6664372 Solution phase synthesis on a soluble homopolymer support by reacting tert-butoxycarbonyl-protected aza-amino acids with bis(pentafluorophenyl) carbonate as carbonyl activation element and coupling to support; combinatorial chemistry
12/16/2003US6664370 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
12/16/2003US6664368 Inhibition of nuclear import by backbone cyclic peptide analogs
12/16/2003US6664367 Cyclic peptides containing modified disulfide bonds coupled with a chelating agent capable of complexing with diagnostic and therapeutically useful metal ions, antineoplastic agents, enzymes, coenzymes or toxins
12/16/2003US6664288 Method and composition for the treatment of cancer
12/16/2003US6664255 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
12/16/2003US6664246 > 1 x 10-7 mole per liter of a vitamin D compound in an acceptable lipid; anticancer agents
1 ... 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 ... 3163